UG1DA013720

NIH – National Institute On Drug Abuse

Psychosocial Factors Linked to Uncontrolled Infection and Mortality among People Living with HIV Who Use Substances: A Latent Class Analysis

Schmidt, R. D., Horigian, V. E., Duan, R., Traynor, S. T., Davis, C. A., Gonzalez, S. T., Forney, D. J., Mandler, R., Del Rio, C., Metsch, L. R., & Feaster, D. J. (2024). Psychosocial Factors Linked to Uncontrolled Infection and Mortality among People Living with HIV Who Use Substances: A Latent Class Analysis. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04410-2
Authors:
Renae D Schmidt
Viviana E Horigian
Rui Duan
Sharleen T Traynor
Carly A Davis
Sophia T Gonzalez
Derrick J Forney
Raul Mandler
Carlos Del Rio
Lisa R Metsch
Daniel J Feaster
Affiliated Authors:
Lisa R Metsch
Author Keywords:
co-occurring conditions
hiv
mental health
substance use disorder
Grants:
UG1DA013720 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1007/s10461-024-04410-2
PMID:
Publication Date:
Data Source:
PubMed

Record Created:

Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment

Luo, S. X., Feaster, D. J., Liu, Y., Balise, R. R., Hu, M.-C., Bouzoubaa, L., Odom, G. J., Brandt, L., Pan, Y., Hser, Y.-I., VanVeldhuisen, P., Castillo, F., Calderon, A. R., Rotrosen, J., Saxon, A. J., Weiss, R. D., Wall, M., & Nunes, E. V. (2024). Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment. JAMA Psychiatry, 81(1), 45. https://doi.org/10.1001/jamapsychiatry.2023.3596
Authors:
Sean X Luo
Daniel J Feaster
Ying Liu
Raymond R Balise
Mei-Chen Hu
Layla Bouzoubaa
Gabriel J Odom
Laura Brandt
Yue Pan
Yih-Ing Hser
Paul VanVeldhuisen
Felipe Castillo
Anna R Calderon
John Rotrosen
Andrew J Saxon
Roger D Weiss
Melanie Wall
Edward V Nunes
Affiliated Authors:
Sean X Luo
Ying Liu
Mei-Chen Hu
Felipe Castillo
Melanie Wall
Edward V Nunes
Grants:
UG1DA013720 (NIH – National Institute On Drug Abuse)
UG1DA013714 (NIH – National Institute On Drug Abuse)
UG1DA013035 (NIH – National Institute On Drug Abuse)
UG1DA015831 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1001/jamapsychiatry.2023.3596
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created:

Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs

Tookes, H. E., Oxner, A., Serota, D. P., Alonso, E., Metsch, L. R., Feaster, D. J., Ucha, J., Suarez, E., Forrest, D. W., McCollister, K., Rodriguez, A., Kolber, M. A., Chueng, T. A., Zayas, S., McCoy, B., Sutherland, K., Archer, C., & Bartholomew, T. S. (2023). Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs. Trials, 24(1). https://doi.org/10.1186/s13063-023-07074-w
Authors:
Hansel E. Tookes
Asa Oxner
David P. Serota
Elizabeth Alonso
Lisa R. Metsch
Daniel J. Feaster
Jessica Ucha
Edward Suarez
David W. Forrest
Kathryn McCollister
Allan Rodriguez
Michael A. Kolber
Teresa A. Chueng
Sheryl Zayas
Bernice McCoy
Kyle Sutherland
Chetwyn Archer
Tyler S. Bartholomew
Affiliated Authors:
Lisa R. Metsch
Author Keywords:
hiv
harm reduction
people who inject drugs
syringe services program
telehealth
Grants:
UG1DA013720 (NIH – National Institute On Drug Abuse)
DP2DA053720 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1186/s13063-023-07074-w
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created:

Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder

Paschen‐Wolff, M., Greenfield, S. F., Kathryn McHugh, R., Burlew, K., Pavlicova, M., Choo, T., Barbosa‐Leiker, C., Ruglass, L. M., Mennenga, S., Rotrosen, J., Nunes, E. V., & Campbell, A. N. C. (2023). Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder. The American Journal on Addictions, 32(6), 584–592. Portico. https://doi.org/10.1111/ajad.13463
Authors:
Margaret Paschen-Wolff
Shelly F Greenfield
R Kathryn McHugh
Kathleen Burlew
Martina Pavlicova
Tse-Hwei Choo
Celestina Barbosa-Leiker
Lesia M Ruglass
Sarah Mennenga
John Rotrosen
Edward V Nunes
Aimee N C Campbell
Affiliated Authors:
Margaret Paschen-Wolff
Martina Pavlicova
Tse-Hwei Choo
Edward V Nunes
Aimee N C Campbell
Grants:
UG1DA013714 (NIH – National Institute On Drug Abuse)
UG1DA015831 (NIH – National Institute On Drug Abuse)
UG1DA013035 (NIH – National Institute On Drug Abuse)
U10DA015833 (NIH – National Institute On Drug Abuse)
U10DA013045 (NIH – National Institute On Drug Abuse)
UG1DA013732 (NIH – National Institute On Drug Abuse)
UG1DA013034 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1111/ajad.13463
PMID:
Publication Date:
Data Source:
PubMed

Record Created:

Health Care Provider Stigma Toward Patients With Substance Use Disorders: Protocol for a Nationally Representative Survey

Parish, C. L., Feaster, D. J., Pollack, H. A., Horigian, V. E., Wang, X., Jacobs, P., Pereyra, M. R., Drymon, C., Allen, E., Gooden, L. K., del Rio, C., & Metsch, L. R. (2023). Health Care Provider Stigma Toward Patients With Substance Use Disorders: Protocol for a Nationally Representative Survey. JMIR Research Protocols, 12, e47548. https://doi.org/10.2196/47548
Authors:
Carrigan Leigh Parish
Daniel J Feaster
Harold A Pollack
Viviana E Horigian
Xiaoming Wang
Petra Jacobs
Margaret R Pereyra
Christina Drymon
Elizabeth Allen
Lauren K Gooden
Carlos Del Rio
Lisa R Metsch
Affiliated Authors:
Carrigan Leigh Parish
Margaret R Pereyra
Lauren K Gooden
Lisa R Metsch
Author Keywords:
substance use disorders
provider stigma
cross-sectional survey study
provider attitudes
survey methodology
Grants:
UG1DA013720 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.2196/47548
PMID:
Publication Date:
Data Source:
PubMed

Record Created:

Capturing drug use patterns at a glance: An n-ary word sufficient statistic for repeated univariate categorical values

Odom, G. J., Brandt, L., Castro, C., Luo, S. X., Feaster, D. J., & Balise, R. R. (2023). Capturing drug use patterns at a glance: An n-ary word sufficient statistic for repeated univariate categorical values. PLOS ONE, 18(9), e0291248. https://doi.org/10.1371/journal.pone.0291248
Authors:
Gabriel J. Odom
Laura Brandt
Clinton Castro
Sean X. Luo
Daniel J. Feaster
Raymond R. Balise
Affiliated Authors:
Sean X. Luo
Grants:
UG1DA013035 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1371/journal.pone.0291248
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created:

Strategies of Managing Repeated Measures: Using Synthetic Random Forest to Predict HIV Viral Suppression Status Among Hospitalized Persons with HIV

Liu, J., Pan, Y., Nelson, M. C., Gooden, L. K., Metsch, L. R., Rodriguez, A. E., Tross, S., del Rio, C., Mandler, R. N., & Feaster, D. J. (2023). Strategies of Managing Repeated Measures: Using Synthetic Random Forest to Predict HIV Viral Suppression Status Among Hospitalized Persons with HIV. AIDS and Behavior, 27(9), 2915–2931. https://doi.org/10.1007/s10461-023-04015-1
Authors:
Jingxin Liu
Yue Pan
Mindy C Nelson
Lauren K Gooden
Lisa R Metsch
Allan E Rodriguez
Susan Tross
Carlos Del Rio
Raul N Mandler
Daniel J Feaster
Affiliated Authors:
Lauren K Gooden
Lisa R Metsch
Susan Tross
Author Keywords:
hiv/aids
longitudinal measurement
machine learning
predictive model
Grants:
P30AI073961 (NIH – National Institute of Allergy and Infectious Diseases)
P30MH116867 (NIH – National Institute of Mental Health)
P30MH133399 (NIH – National Institute of Mental Health)
UG1DA013732 (NIH – National Institute On Drug Abuse)
UG1DA013035 (NIH – National Institute On Drug Abuse)
UG1DA013727 (NIH – National Institute On Drug Abuse)
UG1DA013034 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
UG1DA020024 (NIH – National Institute On Drug Abuse)
UG1DA015831 (NIH – National Institute On Drug Abuse)
U10DA020036 (NIH – National Institute On Drug Abuse)
UG1DA015815 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1007/s10461-023-04015-1
PMID:
Publication Date:
Data Source:
PubMed

Record Created:

High suicidality predicts overdose events among people with substance use disorder: A latent class analysis

Schmidt, R. D., Horigian, V. E., Shmueli-Blumberg, D., Hefner, K., Feinberg, J., Kondapaka, R., Feaster, D. J., Duan, R., Gonzalez, S., Davis, C., Vena, A., Marín-Navarrete, R., & Tross, S. (2023). High suicidality predicts overdose events among people with substance use disorder: A latent class analysis. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1150062
Authors:
Renae D. Schmidt
Viviana E. Horigian
Dikla Shmueli‐Blumberg
Kathryn Hefner
Judith Feinberg
Radhika Kondapaka
Daniel J. Feaster
Rui Duan
Sophia Gonzalez
Carly Davis
Ashley Vena
Rodrigo Marín-Navarrete
Susan Tross
Affiliated Authors:
Susan Tross
Author Keywords:
co-occurring disorders
overdose
substance use
substance use disorder
suicidality
suicide risk
Grants:
U54GM104942 (NIH – National Institute of General Medical Sciences)
UG1DA013035 (NIH – National Institute On Drug Abuse)
UG1DA049436 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.3389/fpubh.2023.1150062
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created:

Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use-Associated Infections: A Prospective Cohort Study With Historical Control

Serota, D. P., Rosenbloom, L., Hervera, B., Seo, G., Feaster, D. J., Metsch, L. R., Suarez, E., Chueng, T. A., Hernandez, S., Rodriguez, A. E., Tookes, H. E., Doblecki-Lewis, S., & Bartholomew, T. S. (2022). Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use–Associated Infections: A Prospective Cohort Study With Historical Control. Open Forum Infectious Diseases, 10(1). https://doi.org/10.1093/ofid/ofac688
Authors:
David P Serota
Liza Rosenbloom
Belén Hervera
Grace Seo
Daniel J Feaster
Lisa R Metsch
Edward Suarez
Teresa A Chueng
Salma Hernandez
Allan E Rodriguez
Hansel E Tookes
Susanne Doblecki-Lewis
Tyler S Bartholomew
Affiliated Authors:
Lisa R Metsch
Author Keywords:
buprenorphine
injection drug use
injection-related infection
opioid use disorder
substance use disorder
Grants:
UG1DA013720 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1093/ofid/ofac688
PMID:
Publication Date:
Data Source:
PubMed

Record Created:

Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes

Bunting, A. M., Krawczyk, N., Choo, T.-H., Pavlicova, M., McNeely, J., Tofighi, B., Rotrosen, J., Nunes, E., & Lee, J. D. (2022). Polysubstance use before and during treatment with medication for opioid use disorder: Prevalence and association with treatment outcomes. Journal of Substance Abuse Treatment, 143, 108830. https://doi.org/10.1016/j.jsat.2022.108830
Authors:
Amanda M Bunting
Noa Krawczyk
Tse-Hwei Choo
Martina Pavlicova
Jennifer McNeely
Babak Tofighi
John Rotrosen
Edward Nunes
Joshua D Lee
Affiliated Authors:
Tse-Hwei Choo
Martina Pavlicova
John Rotrosen
Author Keywords:
polysubstance use
opioid use disorder
buprenorphine
naltrexone
treatment
Grants:
T32HS026120 (NIH – Agency for Healthcare Research and Quality)
UG1DA013732 (NIH – National Institute On Drug Abuse)
UG1DA015831 (NIH – National Institute On Drug Abuse)
U10DA013714 (NIH – National Institute On Drug Abuse)
UG1DA013034 (NIH – National Institute On Drug Abuse)
U10DA013035 (NIH – National Institute On Drug Abuse)
U10DA013720 (NIH – National Institute On Drug Abuse)
R25DA037190 (NIH – National Institute On Drug Abuse)
U10DA015831 (NIH – National Institute On Drug Abuse)
U10DA013045 (NIH – National Institute On Drug Abuse)
U10DA013034 (NIH – National Institute On Drug Abuse)
UG1DA013035 (NIH – National Institute On Drug Abuse)
K23DA042140 (NIH – National Institute On Drug Abuse)
UG1DA013714 (NIH – National Institute On Drug Abuse)
U10DA015833 (NIH – National Institute On Drug Abuse)
U10DA013732 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
K01DA053435 (NIH – National Institute On Drug Abuse)
U10DA013046 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1016/j.jsat.2022.108830
PMID:
Publication Date:
Data Source:
PubMed

Record Created:

Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection Naltrexone

Na, P. J., Scodes, J., Fishman, M., Rotrosen, J., & Jr, E. V. N. (2022). Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder. The Journal of Clinical Psychiatry, 83(3). https://doi.org/10.4088/jcp.21m14140
Authors:
Peter J. Na
Jennifer Scodes
Marc Fishman
John Rotrosen
Edward V. Nunes
Affiliated Authors:
Edward V. Nunes
Grants:
UG1DA013034 (NIH – National Institute On Drug Abuse)
U10DA013732 (NIH – National Institute On Drug Abuse)
UG1DA013732 (NIH – National Institute On Drug Abuse)
U10DA015833 (NIH – National Institute On Drug Abuse)
UG1DA013714 (NIH – National Institute On Drug Abuse)
U10DA013714 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
U10DA013720 (NIH – National Institute On Drug Abuse)
U10DA013034 (NIH – National Institute On Drug Abuse)
K24DA022412 (NIH – National Institute On Drug Abuse)
UG1DA015831 (NIH – National Institute On Drug Abuse)
U10DA013035 (NIH – National Institute On Drug Abuse)
UG1DA013035 (NIH – National Institute On Drug Abuse)
U10DA015831 (NIH – National Institute On Drug Abuse)
U10DA013045 (NIH – National Institute On Drug Abuse)
U10DA013046 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.4088/JCP.21m14140
PMID:
Publication Date:
Data Source:
Scopus

Record Created:

Recruitment into a Clinical Trial of People Living with Uncontrolled HIV Infection Who Inject Drugs: a Site Case Report from the CTN 67 CHOICES Study

Tookes, H., Ucha, J., Rodriguez, A. E., Suarez, E., Alonso, E., Metsch, L. R., Feaster, D. J., Bartholomew, T. S., Hoffman, K. A., & Korthuis, P. T. (2021). Recruitment into a Clinical Trial of People Living with Uncontrolled HIV Infection Who Inject Drugs: a Site Case Report from the CTN 67 CHOICES Study. The Journal of Behavioral Health Services & Research, 49(2), 240–251. https://doi.org/10.1007/s11414-021-09771-3
Authors:
Hansel Tookes
Jessica Ucha
Allan E. Rodriguez
Edward Suarez
Elizabeth Alonso
Lisa R. Metsch
Daniel J. Feaster
Tyler S. Bartholomew
Kim A. Hoffman
P. Todd Korthuis
Affiliated Authors:
Lisa R. Metsch
Grants:
UG1DA013720 (NIH – National Institute On Drug Abuse)
R01DA045713 (NIH – National Institute On Drug Abuse)
UG1DA015815 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1007/s11414-021-09771-3
PMID:
Publication Date:
Data Source:
Scopus

Record Created:

Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs

Gutkind, S., Starbird, L. E., Murphy, S. M., Teixeira, P. A., Gooden, L. K., Matheson, T., Feaster, D. J., Jain, M. K., Masson, C. L., Perlman, D. C., Del Rio, C., Metsch, L. R., & Schackman, B. R. (2022). Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs. Drug and Alcohol Dependence, 232, 109265. https://doi.org/10.1016/j.drugalcdep.2022.109265
Authors:
Sarah Gutkind
Laura E. Starbird
Sean M. Murphy
Paul A. Teixeira
Lauren K. Gooden
Tim Matheson
Daniel J. Feaster
Mamta K. Jain
Carmen L. Masson
David C. Perlman
Carlos Del Rio
Lisa R. Metsch
Bruce R. Schackman
Affiliated Authors:
Laura E. Starbird
Lauren K. Gooden
Lisa R. Metsch
Subjects:
Author Keywords:
hepatitis c
hiv
substance use disorder
cost
care facilitation
Grants:
P30AI073961 (NIH – National Institute of Allergy and Infectious Diseases)
P30AI050409 (NIH – National Institute of Allergy and Infectious Diseases)
T32NR014205 (NIH – National Institute of Nursing Research)
UG1DA020024 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
UG1DA015815 (NIH – National Institute On Drug Abuse)
P30DA040500 (NIH – National Institute On Drug Abuse)
UG1DA013034 (NIH – National Institute On Drug Abuse)
P30DA011041 (NIH – National Institute On Drug Abuse)
T32DA031099 (NIH – National Institute On Drug Abuse)
UG1DA015831 (NIH – National Institute On Drug Abuse)
K01DA051348 (NIH – National Institute On Drug Abuse)
UG1DA013035 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1016/j.drugalcdep.2022.109265
PMID:
Publication Date:
Data Source:
Scopus

Record Created:

Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial

Roache, J. D., Pavlicova, M., Campbell, A., Choo, T., Peavy, M., Kermack, A. S., Nunes, E. V., & Rotrosen, J. (2021). Is extended release naltrexone superior to buprenorphine‐naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial. Alcoholism: Clinical and Experimental Research, 45(12), 2569–2578. Portico. https://doi.org/10.1111/acer.14729
Authors:
John D. Roache
Martina Pavlicova
Aimee Campbell
Tse-Hwei Choo
Michelle Peavy
Andrea S. Kermack
Edward V. Nunes
John Rotrosen
Affiliated Authors:
Martina Pavlicova
Aimee Campbell
Tse-Hwei Choo
Edward V. Nunes
Author Keywords:
alcohol, alcohol use disorder
heavy drinking, treatment
naltrexone, buprenorphine
opioid, opioid use disorder
alcohol
alcohol use disorder
heavy drinking
treatment
naltrexone
buprenorphine
opioid
opioid use disorder
Grants:
UG1DA013034 (NIH – National Institute On Drug Abuse)
U10DA015833 (NIH – National Institute On Drug Abuse)
UG1DA015831 (NIH – National Institute On Drug Abuse)
UG1DA013714 (NIH – National Institute On Drug Abuse)
UG1DA013732 (NIH – National Institute On Drug Abuse)
K24DA022412 (NIH – National Institute On Drug Abuse)
UG1DA013035 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
U10DA013035 (NIH – National Institute On Drug Abuse)
U10DA013045 (NIH – National Institute On Drug Abuse)
U10DA013046 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1111/acer.14729
PMID:
Publication Date:
Data Source:
Scopus

Record Created:

Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis

Murphy, S. M., Jeng, P. J., McCollister, K. E., Leff, J. A., Jalali, A., Shulman, M., Lee, J. D., Nunes, E. V., Novo, P., Rotrosen, J., & Schackman, B. R. (2021). Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis. Addiction (Abingdon, England), 116(12), 3444–3453. https://doi.org/10.1111/add.15531

Authors:
Sean M. Murphy
Philip J. Jeng
Kathryn E. McCollister
Jared A. Leff
Ali Jalali
Matisyahu Shulman
Joshua D. Lee
Edward V. Nunes
Patricia Novo
John Rotrosen
Bruce R. Schackman
Affiliated Authors:
Matisyahu Shulman
Edward V. Nunes
Subjects:
Author Keywords:
buprenorphine-naloxone
cost-effectiveness
efficiency
extended-release naltrexone
induction
opioid detoxification
opioid use disorder
buprenorphine–naloxone
Grants:
K24DA022412 (NIH – National Institute On Drug Abuse)
U10DA013045 (NIH – National Institute On Drug Abuse)
UG1DA015831 (NIH – National Institute On Drug Abuse)
P30DA040500 (NIH – National Institute On Drug Abuse)
U10DA013035 (NIH – National Institute On Drug Abuse)
UG1DA013034 (NIH – National Institute On Drug Abuse)
UG1DA013732 (NIH – National Institute On Drug Abuse)
R01DA035808 (NIH – National Institute On Drug Abuse)
U10DA015833 (NIH – National Institute On Drug Abuse)
U10DA013732 (NIH – National Institute On Drug Abuse)
U10DA013034 (NIH – National Institute On Drug Abuse)
UG1DA013035 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
UG1DA013714 (NIH – National Institute On Drug Abuse)
U10DA015831 (NIH – National Institute On Drug Abuse)
U10DA013714 (NIH – National Institute On Drug Abuse)
U10DA013720 (NIH – National Institute On Drug Abuse)
U10DA013046 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1111/add.15531
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created:

Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial

Fishman, M., Wenzel, K., Scodes, J., Pavlicova, M., Campbell, A. N. C., Rotrosen, J., & Nunes, E. (2021). Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial. The American Journal on Addictions, 30(5), 433–444. Portico. https://doi.org/10.1111/ajad.13176
Authors:
Marc Fishman
Kevin Wenzel
Jennifer Scodes
Martina Pavlicova
Aimee N. C. Campbell
John Rotrosen
Edward Nunes
Affiliated Authors:
Martina Pavlicova
Aimee N. C. Campbell
John Rotrosen
Edward Nunes
Grants:
R61AT010614 (NIH – National Center for Complementary & Integrative Health)
U10DA015831 (NIH – National Institute On Drug Abuse)
U10DA013035 (NIH – National Institute On Drug Abuse)
UG1DA013034 (NIH – National Institute On Drug Abuse)
U10DA013714 (NIH – National Institute On Drug Abuse)
U10DA013720 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
UG1DA013732 (NIH – National Institute On Drug Abuse)
UG1DA013714 (NIH – National Institute On Drug Abuse)
U10DA013732 (NIH – National Institute On Drug Abuse)
U10DA013045 (NIH – National Institute On Drug Abuse)
UG1DA013035 (NIH – National Institute On Drug Abuse)
U10DA013034 (NIH – National Institute On Drug Abuse)
U10DA015833 (NIH – National Institute On Drug Abuse)
UG1DA015831 (NIH – National Institute On Drug Abuse)
U10DA013046 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1111/ajad.13176
PMID:
Publication Date:
Data Source:
Scopus

Record Created:

Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment

Nunes, E. V., Scodes, J. M., Pavlicova, M., Lee, J. D., Novo, P., Campbell, A. N. C., & Rotrosen, J. (2021). Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment. American Journal of Psychiatry, 178(7), 660–671. https://doi.org/10.1176/appi.ajp.2020.20060816
Authors:
Edward V. Nunes
Jennifer M. Scodes
Martina Pavlicova
Joshua D. Lee
Patricia Novo
Aimee N.C. Campbell
John Rotrosen
Affiliated Authors:
Edward V. Nunes
Jennifer M. Scodes
Martina Pavlicova
Aimee N.C. Campbell
Author Keywords:
buprenorphine
criminal justice
extended-release injection naltrexone
homelessness
naltrexone induction
opioid use disorder
relapse
Grants:
UG1DA015831 (NIH – National Institute On Drug Abuse)
U10DA013045 (NIH – National Institute On Drug Abuse)
U10DA013720 (NIH – National Institute On Drug Abuse)
UG1DA013035 (NIH – National Institute On Drug Abuse)
UG1DA013714 (NIH – National Institute On Drug Abuse)
U10DA015831 (NIH – National Institute On Drug Abuse)
K24DA022412 (NIH – National Institute On Drug Abuse)
U10DA013035 (NIH – National Institute On Drug Abuse)
U10DA015833 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
UG1DA013732 (NIH – National Institute On Drug Abuse)
UG1DA013034 (NIH – National Institute On Drug Abuse)
U10DA013732 (NIH – National Institute On Drug Abuse)
U10DA013714 (NIH – National Institute On Drug Abuse)
U10DA013034 (NIH – National Institute On Drug Abuse)
U10DA013046 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1176/appi.ajp.2020.20060816
PMID:
Publication Date:
Data Source:
Scopus

Record Created:

Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use

Traynor, S. M., Metsch, L. R., Gooden, L., Stitzer, M., Matheson, T., Tross, S., Carrico, A. W., Jain, M. K., del Rio, C., & Feaster, D. J. (2021). Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use. Drug and Alcohol Dependence, 221, 108567. https://doi.org/10.1016/j.drugalcdep.2021.108567
Authors:
Sharleen M. Traynor
Lisa R. Metsch
Lauren Gooden
Maxine Stitzer
Tim Matheson
Susan Tross
Adam W. Carrico
Mamta K. Jain
Carlos del Rio
Daniel J. Feaster
Affiliated Authors:
Lisa R. Metsch
Lauren Gooden
Susan Tross
Author Keywords:
hiv
aids
substance use
patient navigation
contingency management
self-efficacy
mediation analysis
hiv/aids
Grants:
U10DA013720 (NIH – National Institute On Drug Abuse)
UG1DA013034 (NIH – National Institute On Drug Abuse)
UG1DA013720 (NIH – National Institute On Drug Abuse)
Publication Type:
Article
Unique ID:
10.1016/j.drugalcdep.2021.108567
PMID:
Publication Date:
Data Source:
Scopus

Record Created: